| |
ERYTHROMYCIN TABLETS 250 mg
(ERYTHROMYCIN STEARATE TABLETS B.P.)
Antibiotic tablets for Oral use.
-----------------------------------------------------------------------------------------------------------------------------
Composition
Each fim coated tablet contains :
Erythromycin stearate B.P. equv. to Erythromycin : 250 mg.
Colour : Erythrosine & Titanium Dioxide
-----------------------------------------------------------------------------------------------------------------------------
Indications
Upper & Lower respiratory tract infections.
Gastrointestinal infections
Skin & soft tissue infections
Eye & Bone infections.
Sexually transmitted diseases
Dosage and Administration
For adults:
250 to 500 mg every 6 hours depending on the severity of the
infection.
For children:
The basic recommendation ranges from 30 to 50 mg/kg/day or
more, depending on the severity of the infections: these
amounts are administered in four divided doses.
Dosage schedule for specific indications:
In streptococcal infections, erythromycin stearate
should be administered at therapeutic dosage for at least 10
days. For continuous prophylaxis of streptococcal infections
or rheumatic fever recurrences in persons with a history of
rheumatic heart disease, the dose is 250 mg twice a day.
Treatment of primary syphilis:
2 - 4 grams per day given in divided doses over a period
of 10 to 15 days.
Treatment of gonorrhoea:
500 mg four times daily for 5 days.
Or as directed by the Physician.
Contraindications
Hypersensitivity to Erythromycin or any of the ingredients.
Severely impaired hepatic function.
Erythromycin is contraindicated in patients taking
terfenadine, astemizole, cisapride, pimozide, and ergotamine
or dihydroergotamine.
-----------------------------------------------------------------------------------------------------------------------------
Presentation
10 Blisters of 10 Tablets each is packed in a carton along
with the insert literature.
1000 Tablets in a jar.
back to top
----------------------------------------------------------------------------------------------------------------------------- |
|
